SkinBioTherapeutics plc (AIM:SBTX)
London flag London · Delayed Price · Currency is GBP · Price in GBX
19.52
-0.23 (-1.16%)
Feb 12, 2026, 3:57 PM GMT

SkinBioTherapeutics Ratios and Metrics

Millions GBP. Fiscal year is Jul - Jun.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Feb '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
5143182232100
Market Cap Growth
22.91%144.31%-17.78%-31.83%-68.11%353.88%
Enterprise Value
474315212994
Last Close Price
0.200.170.090.130.200.64
PS Ratio
10.909.3714.72163.89424.66-
PB Ratio
5.374.625.9910.8512.8319.09
P/TBV Ratio
9.858.48-16.7217.1621.24
EV/Sales Ratio
10.089.3312.45158.92384.18-
Debt / Equity Ratio
0.110.110.280.050.050.03
Asset Turnover
0.540.540.310.050.02-
Inventory Turnover
2.802.802.080.60--
Quick Ratio
4.214.210.633.054.1911.91
Current Ratio
4.844.840.933.254.5812.50
Return on Equity (ROE)
-11.24%-11.24%-115.85%-126.85%-72.62%-37.31%
Return on Assets (ROA)
-8.10%-8.10%-46.50%-66.02%-42.26%-22.00%
Return on Capital Employed (ROCE)
-10.50%-10.50%-85.20%-145.30%-115.80%-28.10%
Earnings Yield
-1.38%-1.60%-16.16%-13.10%-8.80%-1.44%
FCF Yield
-2.46%-2.85%-15.40%-12.64%-8.42%-1.56%
Buyback Yield / Dilution
-22.32%-22.32%-13.10%-5.06%-6.87%-14.53%
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.